
Sweden · Research startup
SmartCella Holding AB is a biotechnology and medtech company based in Tullinge, Sweden, founded in 2014.
Funding reportedLast round: Private equity
SmartCella Holding AB is a biotechnology and medtech company based in Tullinge, Sweden, founded in 2014.
The company specializes in targeted therapies by integrating innovative drug delivery platforms with advanced cell and mRNA therapies. It operates through two main segments: Targeted Deliveries, which focuses on the Extroducer®, an FDA-cleared infusion catheter, and Regenerative Medicines, which develops stem cell-based therapies. The Extroducer® is designed for localized endovascular delivery to hard-to-reach tissues, including cardiac and pancreatic areas, as well as solid tumors. SmartCella also has a proprietary stem cell platform for mRNA therapeutics. The company collaborates with healthcare providers, pharmaceutical partners, and research institutions to address challenging medical conditions, particularly heart failure and solid tumors. With a diverse team of around 30-50 employees, SmartCella is committed to developing life-changing treatments for patients with limited options.
Funding, as reported
From SmartCella Holding AB's own website: 3 on the team.
What they build
Known for
gene therapy deliveryhealth carecell therapy pipelineinnovative neurointerventional techniquesinnovative drug deliverytarget organ accessregulatory clearancebiotechnology researchmanufacturingregenerative cell therapycell therapiesintra-organ injectionendovascular deliverygmp manufacturingextroducer devicegmp manufacturing process
Built with from their website
Google Tag ManagerWordPress.orgPWAApacheYouTubeCloudFlareViewport MetaPriority HintsMicrosoft ExchangeMySQL
PrimeNGMicrosoft 365 Apps & ServicesMobile FriendlyBootstrapLoopiajQueryRSSApple iOS
Add your raise, your deck and your story, and put SmartCella Holding AB in front of investors. Or tell us what we have wrong.